North America Patient Controlled Injectors Market Growth and Forecast by 2027
Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027North America Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country
- Report Date : Dec 2020
- Report Code : TIPRE00017288
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 103
The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027.
The increasing chronic diseases prevalence, and conventional drug delivery system limitations are the key factors driving the growth of patient controlled injectors. However, preference of alternative drug delivery may hinder the North America Patient Controlled Injectors market growth in North America.The patient-controlled injectors are the newest invention in the administration of injections. There are high-unmet needs of people/ HCPs or patients requiring the patient-controlled injectors as it has greater ease and comfort than any other auto-injectors. These are ergonomically developed, and design patient-controlled injectors can help optimize self-care, making it easy for patients to hold the system and administer the dosages at just one press.
Patient-controlled injectors are rapidly gaining their prominence in the market due to their ability to deliver a high volume of viscous formulations. In healthcare settings, the administration of medicines through an intravenous (IV) infusion is expensive. Moreover, self-administration of subcutaneous injections is expected to save 30–70% of costs. Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods, such as wearable injectors. For instance, the SelfDose Patient-Controlled Injector manufactured by West Pharmaceutical Services, Inc. is designed to be ergonomic for optimal patient administration. Additionally, a safety system covers the needle before and after injection to prevent needle stick injuries to the patient and caregiver. Extensive trials of human factors have been carried out of the patient-controlled injector SelfDose, confirming the intuitive nature and encouraging its ease of use and patient acceptance.
A new category of products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life. One such example is Tremfya One-Press—a single-dose, patient-controlled injector, developed by Janssen Pharmaceutical Companies of Johnson & Johnson. The one-press design allows patients to control the rate and pressure of their injection. Moreover, continuous developments by leading players in upgrading the existing patient-controlled injector portfolio is further driving the demand for innovative patient-controlled injectors.
North America has been witnessing growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 10,880,282 with 248,635 deaths reported in the US as of November 13, 2020. The cases are also increasing in Mexico and Canada. Several measures are being taken to contain the disease and prevent the transmission. Patients with severe health conditions, such as diabetes, immune diseases, cardiovascular, cancer, vascular needs physical distancing with others; however, delays in such chronic disease treatments is distressing. Therefore, it is likely to affect the patient controlled injectors market owing to the above mention points.
Mexico Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA PATIENT CONTROLLED INJECTORS MARKET SEGMENTATION
By Product
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
By Application
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
By Country
- US
- Canada
- Mexico
Company Profiles
- Johnson and Johnson Services, Inc.
- West Pharmaceutical Services, Inc
- Enable Injections.
- scPharmaceuticals Inc
- United Therapeutics Corporation
- BD
North America Patient Controlled Injectors Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,261.43 Million |
| Market Size by 2027 | US$ 3,236.46 Million |
| Global CAGR (2020 - 2027) | 12.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Similar Reports
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
Jean-Herve Jenn Chairman, Future Analytica
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
John Suzuki President and Chief Executive Officer, Board Director, BK TechnologiesReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- Johnson and Johnson Services, Inc.
- West Pharmaceutical Services, Inc
- Enable Injections.
- scPharmaceuticals Inc
- United Therapeutics Corporation
- BD
Get Free Sample For